Table 3.

Clinical Characteristics of HIV Positive Patients on HAART in ACSH, Mekele, Ethiopia, 2019

Variables	ZDV Group (N=106)			TDF Group (N=106)		P-value
	Frequency	Valid %		Frequency	Valid %
WHO clinical stage
Stage 1	96	90.60		98	92.50	0.623
Stage2	10	9.60		8	7.50
Adherence
Poor/fair	21	19.80		7	6.60	0.007**
Good	85	80.20		99	93.40
Current isoniazid prophylaxis (IPT)
Yes	34	32.10		25	23.60	0.169
No	72	67.90		81	76.40
Drug addiction
Yes	16	15.00		18	16.98	0.708
No	90	85.00		88	83.02
Cotrimoxazole prophylaxis
Yes	38	35.80		39	36.80	0.886
No	68	64.20		67	63.20
Anemia status
Anemic	43	40.5		28	26.4	0.029*
Non-anemic	63	59.5		78	73.5
Regimen change
Yes	1	0.90		4	3.80	0.175
No	105	99.10		102	96.20

Note: *p<0.05; **p<0.01.

Abbreviations: TDF, tenofovir; ZDV, zidovudine.